CRISPR Therapeutics AGCRSPNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank55
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P55
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-49.08%
2024-123.71%
202376.79%
2022-268.21%
2021193.95%
2020-530.08%
2019135.76%
2018-101.17%
20179.52%
2016-114.77%